Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker.
Roche Holding AG will take over clinical development of an early-stage retinal cell therapy from Lineage Cell Therapeutics in a deal announced on 20 December. Roche-affiliated Genentech, Inc